|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT00688454 |
|
Date of registration:
|
29/05/2008 |
|
Primary sponsor: |
|
|
Public title:
|
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients
|
|
Scientific title:
|
C-Control: Efficacy and Safety of Therapy With Rosuvastatin in Statin-Naive and in Statin-Switched Patients |
|
Date of first enrolment:
|
February 2007 |
|
Target sample size:
|
3392 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT00688454 |
|
Study type:
|
Observational |
|
Study design:
|
Time Perspective: Prospective
|
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Patients with hypercholesteremia who was never treated with statins before
- Patient with hypercholesteremia who was treated with a statin (other then
rosuvastatin) but because of its adverse effects/insufficient action was switched to
therapy with CRESTOR
Exclusion Criteria:
- None
Age minimum:
N/A
Age maximum:
N/A
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Hypercholesteremia
|
|
Primary Outcome(s)
|
|
LDL-Cholesterin, HDL-Cholesterin, Triglycerides, Total Cholesterin
[Time Frame: 3 visits within 10 weeks]
|
|
Secondary Outcome(s)
|
|
Tolerability of CRESTOR-therapy
[Time Frame: 3 visits within 10 weeks]
|
|
Secondary ID(s)
|
|
NIS-CCH-CRE-2007/1
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|